Form 4: Control Empresarial de Capitales S.A. de C.V. Increases Stake in ProKidney Corp.

Control Empresarial de Capitales S.A. de C.V. reports acquiring additional Class A Ordinary Shares of ProKidney Corp., increasing their beneficial ownership.

Summary

• Control Empresarial de Capitales S.A. de C.V. acquired 387,393 Class A Ordinary Shares of ProKidney Corp. on April 22, 2025, at a weighted average price of $0.7134 per share.
• The total number of Class A Ordinary Shares beneficially owned by Control Empresarial following the transaction is 73,842,723.
• This includes 63,118,645 Class B Ordinary Shares, which have no economic rights but entitle the holder to vote and can be exchanged for Class A Ordinary Shares.
• The Slim Family may be deemed to beneficially own indirectly the Class A Ordinary Shares beneficially owned by Control Empresarial.
• The Slim Family may also be deemed to beneficially own approximately 25.2% of the 292,697,649 total shares issued and outstanding, comprising 129,536,121 Class A Ordinary Shares and 163,161,528 Class B Ordinary Shares, as disclosed in the Issuers Form 10-K filed with the SEC on March 17, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard SEC filing reporting a transaction. The increased stake could be viewed positively, but without further context, it's difficult to assess the overall impact.

Positives

• Increased investment by a major shareholder could signal confidence in the company's future prospects.

Risks

• The document does not provide specific reasons for the share purchase, so the underlying motivation is unknown.
• The earnout rights are contingent on achieving specific share price milestones, which may not be met.

Future Outlook

The document does not contain explicit forward-looking statements, but the earnout rights vest based on future share price performance.

Industry Context

Form 4 filings are a standard part of regulatory compliance for individuals and entities with significant ownership in publicly traded companies, providing transparency into insider transactions.

Stakeholder Impact

• The increased stake by Control Empresarial could potentially increase shareholder confidence.

Key Dates

Keywords

ProKidney Corp, Control Empresarial, Class A Ordinary Shares, Class B Ordinary Shares, Beneficial Ownership, Slim Family, SEC Form 4